Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer

por Venturelli, Marta, Guaitoli, Giorgia, Omarini, Claudia, Moscetti, Luca
Publicado 2018

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

por Omarini, Claudia, Guaitoli, Giorgia, Pipitone, Stefania, Moscetti, Luca, Cortesi, Laura, Cascinu, Stefano, Piacentini, Federico
Publicado 2018

Male mammary myofibroblastoma: Two case reports and brief review of literature

por Venturelli, Marta, Toss, Angela, Cortesi, Laura, Gambini, Anna, Andreotti, Alessia, Cascinu, Stefano, Tazzioli, Giovanni, Moscetti, Luca
Publicado 2020

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review

por Canino, Fabio, Piacentini, Federico, Omarini, Claudia, Toss, Angela, Barbolini, Monica, Vici, Patrizia, Dominici, Massimo, Moscetti, Luca
Publicado 2022

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to presc...

por Omarini, Claudia, Piacentini, Federico, Sperduti, Isabella, Barbolini, Monica, Isca, Chrystel, Toss, Angela, Cortesi, Laura, Barbieri, Elena, Dominici, Massimo, Moscetti, Luca
Publicado 2020

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis

por Omarini, Claudia, Piacentini, Federico, Sperduti, Isabella, Cerma, Krisida, Barbolini, Monica, Canino, Fabio, Nasso, Cecilia, Isca, Christel, Caggia, Federica, Dominici, Massimo, Moscetti, Luca
Publicado 2022

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

por Cerma, Krisida, Piacentini, Federico, Moscetti, Luca, Barbolini, Monica, Canino, Fabio, Tornincasa, Antonio, Caggia, Federica, Cerri, Sara, Molinaro, Alessia, Dominici, Massimo, Omarini, Claudia
Publicado 2023

Management of PALB2‐associated breast cancer: A literature review and case report

por Toss, Angela, Ponzoni, Ornella, Riccò, Beatrice, Piombino, Claudia, Moscetti, Luca, Combi, Francesca, Palma, Enza, Papi, Simona, Tenedini, Elena, Tazzioli, Giovanni, Dominici, Massimo, Cortesi, Laura
Publicado 2023

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature

por Isca, Chrystel, Piacentini, Federico, Mastrolia, Ilenia, Masciale, Valentina, Caggia, Federica, Toss, Angela, Piombino, Claudia, Moscetti, Luca, Barbolini, Monica, Maur, Michela, Dominici, Massimo, Omarini, Claudia
Publicado 2021

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

por Omarini, Claudia, Filieri, Maria Elisabetta, Bettelli, Stefania, Manfredini, Samantha, Kaleci, Shaniko, Caprera, Cecilia, Nasso, Cecilia, Barbolini, Monica, Guaitoli, Giorgia, Moscetti, Luca, Maiorana, Antonino, Conte, Pier Franco, Cascinu, Stefano, Piacentini, Federico
Publicado 2018

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

por Toss, Angela, Piacentini, Federico, Cortesi, Laura, Artuso, Lucia, Bernardis, Isabella, Parenti, Sandra, Tenedini, Elena, Ficarra, Guido, Maiorana, Antonino, Iannone, Anna, Omarini, Claudia, Moscetti, Luca, Cristofanilli, Massimo, Federico, Massimo, Tagliafico, Enrico
Publicado 2018

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

por Omarini, Claudia, Palumbo, Patrizia, Pecchi, Annarita, Draisci, Stefano, Balduzzi, Sara, Nasso, Cecilia, Barbolini, Monica, Isca, Chrystel, Bocconi, Alessandro, Moscetti, Luca, Galetti, Silvia, Tazzioli, Giovanni, Torricelli, Pietro, Cascinu, Stefano, Piacentini, Federico
Publicado 2019

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

por Fabi, Alessandra, Felici, Alessandra, Metro, Giulio, Mirri, Alessandra, Bria, Emilio, Telera, Stefano, Moscetti, Luca, Russillo, Michelangelo, Lanzetta, Gaetano, Mansueto, Giovanni, Pace, Andrea, Maschio, Marta, Vidiri, Antonello, Sperduti, Isabella, Cognetti, Francesco, Carapella, Carmine M
Publicado 2011

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: R...

por Pizzuti, Laura, Natoli, Clara, Gamucci, Teresa, Mauri, Mariella, Sergi, Domenico, Di Lauro, Luigi, Paoletti, Giancarlo, Ruggeri, Enzo, Iezzi, Laura, Sperduti, Isabella, Mentuccia, Lucia, Fabbri, Agnese, Maugeri-Saccà, Marcello, Moscetti, Luca, Barba, Maddalena, Vici, Patrizia
Publicado 2017

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

por Moscetti, Luca, Hennik, Paula, Bolstad, Bjorg, Camarero, Jorge, Josephson, Filip, Melchiorri, Daniela, Sommerfelt Grønvold, Maja, Sjoberg, Jan, Botezatu, Mihaela, Mulder, Jorn, Meulendijks, Didier, Trullas Jimeno, Ana, Zafiropoulos, Nikolaos, Bergh, Jonas, Enzmann, Harald, Pignatti, Francesco
Publicado 2020

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

por Toss, Angela, Venturelli, Marta, Civallero, Monica, Piombino, Claudia, Domati, Federica, Ficarra, Guido, Combi, Francesca, Cabitza, Eleonora, Caggia, Federica, Barbieri, Elena, Barbolini, Monica, Moscetti, Luca, Omarini, Claudia, Piacentini, Federico, Tazzioli, Giovanni, Dominici, Massimo, Cortesi, Laura
Publicado 2022

Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study

por Gamucci, Teresa, Michelotti, Andrea, Pizzuti, Laura, Mentuccia, Lucia, Landucci, Elisabetta, Sperduti, Isabella, Di Lauro, Luigi, Fabi, Alessandra, Tonini, Giuseppe, Sini, Valentina, Salesi, Nello, Ferrarini, Ilaria, Vaccaro, Angela, Pavese, Ida, Veltri, Enzo, Moscetti, Luca, Marchetti, Paolo, Vici, Patrizia
Publicado 2014

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial

por Moscetti, Luca, Fabbri, Maria Agnese, Natoli, Clara, Vici, Patrizia, Gamucci, Teresa, Sperduti, Isabella, Iezzi, Laura, Iattoni, Elena, Pizzuti, Laura, Roma, Carmine, Vaccaro, Angela, D’Auria, Giuliana, Mauri, Mariella, Mentuccia, Lucia, Grassadonia, Antonino, Barba, Maddalena, Ruggeri, Enzo Maria
Publicado 2017

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

por Natoli, Clara, Vici, Patrizia, Sperduti, Isabella, Grassadonia, Antonino, Bisagni, Giancarlo, Tinari, Nicola, Michelotti, Andrea, Zampa, Germano, Gori, Stefania, Moscetti, Luca, De Tursi, Michele, Panebianco, Michele, Mauri, Maria, Ferrarini, Ilaria, Pizzuti, Laura, Ficorella, Corrado, Samaritani, Riccardo, Mentuccia, Lucia, Iacobelli, Stefano, Gamucci, Teresa
Publicado 2013

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis o...

por Orlandi, Armando, Iattoni, Elena, Pizzuti, Laura, Fabbri, Agnese, Botticelli, Andrea, Di Dio, Carmela, Palazzo, Antonella, Garufi, Giovanna, Indellicati, Giulia, Alesini, Daniele, Carbognin, Luisa, Paris, Ida, Vaccaro, Angela, Moscetti, Luca, Fabi, Alessandra, Magri, Valentina, Naso, Giuseppe, Cassano, Alessandra, Vici, Patrizia, Giannarelli, Diana, Franceschini, Gianluca, Marchetti, Paolo, Bria, Emilio, Tortora, Giampaolo
Publicado 2020